Fortrea Holdings Inc. (FTRE) stock
FTRENasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/3058% above fair value
$18.55−1.60 (-7.94%)
Close on Nov 20, 2026Market cap $1.79BP/E –Yield –
Fortrea free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Fortrea's free cash flow for the twelve months ending Sep 30, 2026 was $169.00M. For fiscal 2025 it was $88.30M, down 62.8% from the year before. The highest annual figure on record is $237.30M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $88.30M | -62.8% |
| FY2024 | Dec 31, 2024 | $237.30M | +85.2% |
| FY2023 | Dec 31, 2023 | $128.10M | +352.7% |
| FY2022 | Dec 31, 2022 | $28.30M | -80.3% |
| FY2021 | Dec 31, 2021 | $143.30M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $52.50M | -34.0% |
| Q2 FY2026 | Jun 30, 2026 | $19.90M | +39.2% |
| Q1 FY2026 | Mar 31, 2026 | -$25.00M | – |
| Q4 FY2025 | Dec 31, 2025 | $121.60M | +499.0% |
| Q3 FY2025 | Sep 30, 2025 | $79.50M | – |
| Q2 FY2025 | Jun 30, 2025 | $14.30M | -94.6% |
| Q1 FY2025 | Mar 31, 2025 | -$127.10M | – |
| Q4 FY2024 | Dec 31, 2024 | $20.30M | +125.6% |
| Q3 FY2024 | Sep 30, 2024 | -$10.60M | – |
| Q2 FY2024 | Jun 30, 2024 | $262.50M | +86.8% |
| Q1 FY2024 | Mar 31, 2024 | -$34.90M | – |
| Q4 FY2023 | Dec 31, 2023 | $9.00M | +76.5% |
| Q3 FY2023 | Sep 30, 2023 | -$3.20M | -105.0% |
| Q2 FY2023 | Jun 30, 2023 | $140.50M | – |
| Q1 FY2023 | Mar 31, 2023 | -$18.20M | – |
| Q4 FY2022 | Dec 31, 2022 | $5.10M | – |
| Q3 FY2022 | Sep 30, 2022 | $63.90M | – |
See a number that looks wrong?